Newkirk M M, Rauch J
Department of Medicine, McGill University, Montreal General Hospital Research Institute, Quebec, Canada.
Rheumatol Int. 1994;13(5):203-9. doi: 10.1007/BF00390268.
Among 38 human hybridoma-derived monoclonal rheumatoid factors (RFs) generated from patients with either rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE), two groups of RFs can be identified. Monospecific RFs were derived primarily from patients with RA and are characterized by a binding specificity for IgG3 and/or IgG4. Polyreactive RFs were derived largely from patients with SLE and show a broader pattern of reactivity to all four isotypes of IgG. Neither population of RFs was exclusive to either disease. The binding specificities identified appear to be different from the RFs isolated from patients with mixed cryoglobulinemia and may reflect a different antigen selection mechanism.
在从类风湿关节炎(RA)或系统性红斑狼疮(SLE)患者中产生的38种人杂交瘤衍生的单克隆类风湿因子(RFs)中,可以识别出两组RFs。单特异性RFs主要来自RA患者,其特征是对IgG3和/或IgG4具有结合特异性。多反应性RFs主要来自SLE患者,对IgG的所有四种亚型均表现出更广泛的反应模式。这两种RFs群体并非某一种疾病所特有。所确定的结合特异性似乎与从混合性冷球蛋白血症患者中分离出的RFs不同,可能反映了不同的抗原选择机制。